Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Diseases

Free Subscription Articles published in Ann Intern Med Retrieve available abstracts of 17 articles: HTML format

Single Articles

July 2024
1. SIMON TG, Singer DE, Zhang Y, Mastrorilli JM, et al
   Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation : A Nationwide Cohort Study.
   Ann Intern Med. 2024 Jul 9. doi: 10.7326/M23-3067.
   PubMed     Abstract available
   
   
   June 2024
2. MIRONOVA M, Sherker AH
   In NASH with liver fibrosis, resmetirom improved NASH resolution and reduced fibrosis at 1 y.
   Ann Intern Med. 2024;177:JC63.
   PubMed     Abstract available
   
   
   April 2024
3. LAKE JE, Kitch DW, Kantor A, Muthupillai R, et al
   The Effect of Open-Label Semaglutide on Metabolic Dysfunction-Associated Steatotic Liver Disease in People With HIV.
   Ann Intern Med. 2024 Apr 30. doi: 10.7326/M23-3354.
   PubMed    
   
   
   
4. ANVARI S, Dadgar K, Galts C, Bretthauer M, et al
   Gastroenterology/Hepatology: What You May Have Missed in 2023.
   Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0505.
   PubMed     Abstract available
   
   
   June 2023
5. LEE BP, Dodge JL, Mack WJ, Leventhal AM, et al
   National Trends in Alcohol Use, Metabolic Syndrome, and Liver Disease From 1999 to 2018.
   Ann Intern Med. 2023;176:879-882.
   PubMed    
   
   
   February 2023
6. MUKHERJEE S
   In nonalcoholic fatty liver disease, a diet of freshwater fish vs. freshwater fish plus red meat reduced liver fat.
   Ann Intern Med. 2023;176:JC20.
   PubMed     Abstract available
   
   
   December 2022
7. 
   Summary for Patients: Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.
   Ann Intern Med. 2022 Dec 13. doi: 10.7326/P22-0022.
   PubMed    
   
   
   
8. HANSEN CD, Gram-Kampmann EM, Hansen JK, Hugger MB, et al
   Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease : A Randomized Controlled Trial.
   Ann Intern Med. 2022 Dec 13. doi: 10.7326/M22-1787.
   PubMed     Abstract available
   
   
   July 2022
9. CEPEDA JA, Thomas DL, Astemborski J, Rudolph JE, et al
   Impact of Hepatitis C Treatment Uptake on Cirrhosis and Mortality in Persons Who Inject Drugs : A Longitudinal, Community-Based Cohort Study.
   Ann Intern Med. 2022 Jul 12. doi: 10.7326/M21-3846.
   PubMed     Abstract available
   
   
   
10. KORETZ RL
    Aspirin use is associated with reduced risk for hepatocellular carcinoma.
    Ann Intern Med. 2022 Jul 5. doi: 10.7326/J22-0049.
    PubMed     Abstract available
    
    
    
11. WEITZ HH, Merli GJ
    Web Exclusive. Annals Consult Guys - Portal Vein Thrombosis: What Could Be the Cause?
    Ann Intern Med. 2022;175:CG1.
    PubMed    
    
    
    November 2021
12. SEEBERG KA, Borgeraas H, Hofso D, Smastuen MC, et al
    Gastric Bypass Versus Sleeve Gastrectomy in Type 2 Diabetes: Effects on Hepatic Steatosis and Fibrosis : A Randomized Controlled Trial.
    Ann Intern Med. 2021 Nov 30. doi: 10.7326/M21-1962.
    PubMed     Abstract available
    
    
    
13. 
    Summary for Patients: Do Gastric Bypass and Sleeve Gastrectomy Help Reduce Liver Fat Content and Scarring in Patients With Type 2 Diabetes?
    Ann Intern Med. 2021 Nov 30. doi: 10.7326/P21-0012.
    PubMed    
    
    
    September 2021
14. TRAN AN, Lim JK
    Care of the Patient With Abnormal Liver Test Results.
    Ann Intern Med. 2021;174:ITC129-ITC144.
    PubMed     Abstract available
    
    
    August 2021
15. HERCUN J, Sherker AH
    In decompensated cirrhosis, targeted albumin infusions did not improve an in-hospital composite outcome at 15 d.
    Ann Intern Med. 2021 Aug 3. doi: 10.7326/ACPJ202108170.
    PubMed     Abstract available
    
    
    July 2021
16. KORETZ RL
    In patients having transjugular intrahepatic portosystemic shunt, rifaximin prevented overt hepatic encephalopathy.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/ACPJ202107200.
    PubMed     Abstract available
    
    
    
17. TAPPER EB, Bosch J
    Annals for Hospitalists Inpatient Notes - Clinical Pearls-Hepatorenal Syndrome.
    Ann Intern Med. 2021;174:HO2-HO3.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.